Remdesivir has emerged as a major treatment option for suspected or laboratory confirmed cases of COVID-19. Initial experience with remdesivir in patients with COVID‐19 emerged in the form of case reports and case series. However, there is a need for clinicians to continue to share their experience with each other.
IMA-Karnataka welcomes doctors to this informative recorded session on "Use of Remdesivir in treating patients with COVID-19 (Experience sharing & Updates from Clinical Trials)"
During this event, our speakers were:
1. Dr. Vishnu Sharma, M.D. Tuberculosis and Respiratory Diseases , shared his experience on " Use of Remdesivir in treating patients with severe COVID-19, case presentations".
2. Dr. Ravindra Mehta, Chief of Critical Care, Consultant pulmonologist/Sleep Medicine Specialities, Apollo Hospitals, Bangalore, shared "Remdesivir in COVID19 - Current status and Practical Issues".
Moderator for this event was:
Dr. Somnath S.M, Consultant Physician, Sanjana Diabetes and Eye Care, Ballari.
Host Panelists were:
1. Dr. Madhusudana Kariganur, President, IMA Karnataka State
2. Dr. Srinivasa S.,Honorary State Secretary, IMA Karnataka
We wish you a great learning experience and thank IMA-Karnataka for hosting this session. We also thank our sponsors Mylan Pharmaceuticals Pvt. Ltd. to make this program possible.